Isabelle L. Coquard-Ray

Faculté De Médecine Lyon Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 568 publications

Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer.

Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer.

Journal: CA: a cancer journal for clinicians

Published: July 17, 2026

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 02, 2026

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

Journal: JAMA oncology

Published: June 25, 2026

New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.

New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.

Journal: Nature reviews. Clinical oncology

Published: June 17, 2026

Response to Yu, Wang and Ge.

Response to Yu, Wang and Ge.

Journal: Journal of the National Cancer Institute

Published: June 15, 2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Journal: Cancer treatment reviews

Published: June 09, 2026

Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].

Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].

Journal: Gynecologic oncology

Published: June 02, 2026

Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society.

Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 28, 2026

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 15, 2026

Role of surgery in stage IV high-grade serous ovarian cancer: a French population-based multi-center study using Epidemiological Strategy and Medical Economics ovarian cancer database.

Role of surgery in stage IV high-grade serous ovarian cancer: a French population-based multi-center study using Epidemiological Strategy and Medical Economics ovarian cancer database.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 30, 2026

Hold the line: Local control strategies in oligoprogressive gynecologic cancers during systemic therapy.

Hold the line: Local control strategies in oligoprogressive gynecologic cancers during systemic therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 29, 2026

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 28, 2026

Showing 1-12 of 568

Last Updated: 09/26/2026